The Thermo Scientific Heracell i CO2 incubator features variable oxygen control. Ideal for advanced applications in the area of stem cell research, regenerative and personalized medicine and other protocols that necessitate reduced oxygen concentrations, the incubator models are also available for hypoxic experimentation where oxygen levels above atmospheric levels are required.
New therapy approach goes directly to the source of cancer development.
Many proteins interact with an RNA molecule called Xist to coat and silence one X chromosome in every female cell. Learning how genes are targeted and silenced may help researchers studying sex-specific diseases.
Health officials in Indiana on Saturday began a needle-exchange program Saturday in a county where an HIV outbreak among intravenous drug users has grown to nearly 90 cases.
Genetic studies in humans, zebrafish and mice have revealed how two different types of genetic variations team up to cause a rare condition called Hirschsprung’s disease.
Study suggests adults infected with HIV can develop age-related diseases a decade earlier than their uninfected peers.
Laurie Boyer’s studies of stem cell differentiation could improve treatments for heart disease.
A test that detects fetal DNA in the mother’s bloodstream is more accurate than conventional screening at identifying Down syndrome (aka trisomy 21), finds a new study led by researchers at Columbia University Medical Center and UCSF.
A drug-resistant strain of a nasty stomach bug made its way into the U.S. and spread, causing more than 200 illnesses since last May, health officials said Thursday.
Hydrothermal vents on a Saturn moon are so similar to life-ridden hydrothermal vents on Earth, scientists think they may find life up there, says a report in Nature.
The oocytes (eggs) of chimpanzees degrade at a slower rate than the oocytes of women, even though chimps do not live as long.
It's not just people who love the food in New York City. So do certain ants.
New finding is expected to expand therapeutic and experimental applications of CRISPR.
We’re investing in our valued readers with a creative new approach to delivering editorial content for Bioscience Technology that you can use in your daily work and life. It’s a bold, new approach as our staff editors, expert contributors and real-time reporters gather information on critical issues—and offer in-depth reports and track the pulse of your industry. It’s our commitment to our Science and Technology audience.